Recurrent Acute Leukemia of Ambiguous Lineage: Clinical Trials

2 trials for Recurrent Acute Leukemia of Ambiguous Lineage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Active not recruiting 1

Follow Recurrent Acute Leukemia of Ambiguous Lineage: new trials by email Literature Review of Recurrent Acute Leukemia of Ambiguous Lineage trials Research Report on Recurrent Acute Leukemia of Ambiguous Lineage

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Biospecimen Collection, Bone Marrow Aspiration, Calaspargase Pegol - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia
Phase 2Active not recruitingChildren's Oncology Group782024-01-082026-08-25
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
Chemosensitivity Assay, Cytology Specimen Collection Procedure, Gene Expression Analysis - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia
Not applicableCompletedUniversity of Washington342015-09-112022-06-30

Narrower conditions

Leukemia, Biphenotypic, Acute (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Leukemia, Myeloid, Acute (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Leukemia, Myeloid (1)

Interventions

Asparaginase (1)  ·  Cytarabine (1)  ·  Gene Expression Profiling (1)  ·  Genetic Variation (1)  ·  Hydrocortisone (1)  ·  Methotrexate (1)  ·  Methylprednisolone (1)  ·  Prednisolone (1)  ·  Prednisone (1)  ·  Specimen Handling (1)  ·  Spinal Puncture (1)  ·  Vincristine (1)  ·  calaspargase pegol (1)  ·  deltacortene (1)  ·  fludarabine phosphate (1)

Sponsors

Children's Oncology Group (1)  ·  University of Washington (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Kelly E Faulk (1)  ·  Mary-Elizabeth Percival (1)

NIH funding

P30CA015704 (1), U10CA180886 (1)